Rosa Giuliani
Impact in
- Oncology top 5%
- Cancer Risks and Factors
- Cancer Treatment and Pharmacology
- HER2/EGFR in Cancer Research
- Colorectal Cancer Treatments and Studies
-
- Breast Cancer Treatment Studies
Papers in
- Oncology 21
- Cancer Treatment and Pharmacology 9
- Colorectal Cancer Treatments and Studies 8
- HER2/EGFR in Cancer Research 5
-
- Health Systems, Economic Evaluations, Quality of Life 8
- Economic and Financial Impacts of Cancer 3
- Co-authors
- Solange Peters (3 shared papers)Elisabeth G.E. de Vries (4 shared papers)Martine Piccart (5 shared papers)Fátima Cardoso (3 shared papers)Francesco Pignatti (6 shared papers)Malvika Vyas (3 shared papers)Josep Tabernero (3 shared papers)Marina Chiara Garassino (1 shared paper)
- Journals
- ESMO Open (7 papers)Journal of Clinical Oncology (7 papers)Annals of Oncology (4 papers)The Oncologist (2 papers)Clinical Cancer Research (1 paper)
- Partner nations
- ItalyNetherlandsUnited Kingdom
In The Last Decade
Rosa Giuliani
30 papers receiving 786 citations
Peers
Comparison fields: 5 of 80
- Oncology 524
- Cancer Research 155
- Immunology 127
- Hematology 60
- Hepatology 38
Countries citing papers authored by Rosa Giuliani
This map shows the geographic impact of Rosa Giuliani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rosa Giuliani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rosa Giuliani more than expected).
Fields of papers citing papers by Rosa Giuliani
This network shows the impact of papers produced by Rosa Giuliani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rosa Giuliani. The network helps show where Rosa Giuliani may publish in the future.
Co-authors
The 25 scholars most cited alongside Rosa Giuliani, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 136 | |
| 2 | 2009 | 128 | |
| 3 | 2016 | 88 | |
| 4 | 2021 | 64 | |
| 5 | 2023 | 51 | |
| 6 | 2013 | 44 | |
| 7 | 2019 | 38 | |
| 8 | Hepatic arterial continuous infusion (HACI) of oxaliplatin in patients with unresectable liver metastases from colorectal cancer. | 2003 | 32 |
| 9 | 2009 | 31 | |
| 10 | 2021 | 28 | |
| 11 | 2012 | 28 | |
| 12 | 2005 | 16 | |
| 13 | 2000 | 15 | |
| 14 | 2000 | 15 | |
| 15 | 2014 | 14 | |
| 16 | 2021 | 12 | |
| 17 | 2002 | 10 | |
| 18 | 2022 | 9 | |
| 19 | 2013 | 9 | |
| 20 | 2018 | 7 |
About Rosa Giuliani
Rosa Giuliani is a scholar working on Oncology, Economics and Econometrics, Cancer Research, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging, having authored 31 papers that have together received 805 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (9 papers), Colorectal Cancer Treatments and Studies (8 papers), Health Systems, Economic Evaluations, Quality of Life (8 papers), HER2/EGFR in Cancer Research (5 papers), Breast Cancer Treatment Studies (4 papers), Biosimilars and Bioanalytical Methods (4 papers), Economic and Financial Impacts of Cancer (3 papers) and Pharmaceutical studies and practices (3 papers). The work is most often cited by research in Oncology (524 citations), Cancer Research (155 citations), Immunology (127 citations), Hematology (60 citations) and Hepatology (38 citations). Rosa Giuliani has collaborated with scholars based in Italy, Netherlands and United Kingdom. Frequent co-authors include Solange Peters, Elisabeth G.E. de Vries, Martine Piccart, Fátima Cardoso, Francesco Pignatti, Malvika Vyas, Josep Tabernero, Marina Chiara Garassino, Ravindran Kanesvaran and Tomas Salmonson. Their work appears in journals such as ESMO Open, Journal of Clinical Oncology, Annals of Oncology, The Oncologist and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.